Sartorius Stedim Biotech completed the acquisition of chromatography process equipment division from Novasep.

Sartorius Stedim Biotech, a international partner of the biopharmaceutical industry, completed the acquisition of chromatography process equipment division from Novasep, a provider of services in the field of molecule production and purification for the life science industries. Financial terms were not disclosed. "The Novasep portfolio will perfectly complement our existing chromatography offering and allow us to provide customers with more options for their manufacturing processes. Efficient downstream processing has remained a challenge in our industry for years, and Sartorius Stedim Biotech is committed to helping accelerate and simplify this crucial step so that new drugs can be manufactured much more efficiently," René Fáber, Sartorius Stedim Biotech Member of the Board of Directors.